GLGC Gene Logic Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GLGC Gene Logic

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (352)	12/11/2007 10:23:50 AM
From: Mike McFarland	Read Replies (1) of 360

Ore Pharmaceuticals--New symbol will be ORXE shareholders have approved both the sale of its Genomics Assets to Ocimum Biosolutions and the renaming of the Company as Ore Pharmaceuticals Inc. The shareholder vote yesterday and completion of the sale of the Genomics Assets expected later this week will launch effectively Ore Pharmaceuticals as a new company focused on drug repositioning and development. After the filing of necessary legal documents later this week, the Company will be renamed Ore Pharmaceuticals Inc. The Company’s stock will continue to trade on the NASDAQ exchange and its stock ticker will change to ORXE. Ownership of the name Gene Logic will transfer to Ocimum on the date of closing of the sale agreement. snip

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next